Recorded 2024 LIVE @ LUNCH - HFPEF: TIME FOR A DEEPER LOOK
LIVE @ LUNCH - HFpEF: Time for a Deeper Look webinar is part of our LIVE @ LUNCH Webinar Subscription. There are five 1-hour courses included in this webinar series and each can be purchased separately for $25 each. If you are interested in signing up for the $100 webinar subscription for all 5 LIVE @ LUNCH programs, you may do so by clicking on the following link below and will receive a code to register for all 2024 Live @ Lunch webinars.
LIVE @ LUNCH WEBINAR SUBSCRIPTION
LIVE @ LUNCH subscription for $100 includes:
- April 24th from 12-1pm
- HFpEF: Time for a Deeper Look
- June 18th from 12-1pm
- August 7th from 12-1pm
- Advances in RSV Prevention Across Multiple Populations
- October 30th from 12-1pm
- OTC Update: Combatting Cough & Cold Symptoms
- December 4th from 12-1pm
- New Drug Update 2024
By continuing here and registering, you are signed up for only this LIVE @ LUNCH - HFpEF: Time for a Deeper Look CE program and NOT the subscription of 5 courses.
Target Audience
This experience and knowledge-based program is intended for Pharmacists (ACPE) and Nurses (ABN).
Learning Objectives
- Differentiate the clinical characteristics of heart failure with preserved ejection fraction from heart failure with reduced ejection fraction.
- Discuss the role of currently recommended drug classes for the treatment of heart failure with preserved ejection fraction.
- Develop a treatment plan for a patient with heart failure with preserved ejection fraction.
Heart Failure with preserved Ejection Fraction (HFpEF) affects between 1.1-5.5% of the general population, with a prevalence of > 10% in older adults (> 75 years of age). Patients with HFpEF suffer from significant morbidity and mortality, however traditional therapies used to manage Heart Failure with reduced Ejection Fraction (HFrEF), have failed to reduce morbidity or mortality in these patients. Recently, sodium-glucose cotransporter 2 (SGLT2) inhibitors have demonstrated benefits in this population, but limitations in data pose questions regarding application to routine patient care. Further, new recommendations for both mineralocorticoid receptor antagonists (MRA) and angiotensin receptor blocker neprilysin inhibitors (ARNI) warrant a closer look. This session will discuss an initial overview of HFpEF, the "traditional" approach to management, and gaps in patient care; next an interactive discussion of recently evaluated entities for HFpEF, including MRA, ARNI and SGLT2 inhibitors. A case based format will be used.
Recorded LIVE @ LUNCH - HFpEF Time for a Deeper Look PROGRAM PACKET.pdf
A copy of the presentation slides are located within the course content. Once you have registered for the course, please navigate to the 'Take Course' tab and click the navy blue 'Take Course' button. Navigate to the 'Course Materials' section of the course using the left-hand menu and download a PDF version of the program presentation.
Any directions needed to venue here
Jessica Starr, PharmD, FCCP, BCPS is an Associate Clinical Professor in the Department of Pharmacy Practice at the Harrison College of Pharmacy. Originally from Pensacola, Florida, Dr. Starr completed her pre-pharmacy coursework at the University of California, Santa Barbra and graduated with her Doctor of Pharmacy from the Harrison College of Pharmacy. After graduation, she moved to Charleston, South Carolina where she completed an ASHP-accredited pharmacy practice residency and a specialty residency in adult internal medicine at the Medical University of South Carolina.
Dr. Starr is extensively involved in curricular design for the practice ready curriculum where she serves as the course coordinator for the P3 fall semester. She has developed and currently executes the evidenced-based medicine course work which is integrated throughout the first three professional years. Her primary area of expertise is cardiovascular pharmacotherapy where she has both mapped and extensively taught these disease states during the P1, P2, and P3 years. She also offers both an IPPE and APPE clinical rotation in Internal Medicine at her practice site, Princeton Baptist Medical Center.
Dr. Starr has received numerous awards while at the Harrison College of Pharmacy. She was awarded the Lucinda Maine Fellow in Teaching which recognizes a faculty member who has excelled in the effort to create a powerful and inspiring learning environment that establishes the school as the leading destination for outstanding Doctor of Pharmacy and Graduate Students. Dr. Starr also received the college’s inaugural Excellence in Outreach award for her work at Princeton Baptist Medical Center. She has been recognized as a Preceptor of Excellence numerous times and has received the Rho Chi Distinguished Alumni Award.
Dr. Starr is extensively involved in both the American Society of Health-System Pharmacists (ASHP) and the American College of Clinical Pharmacy (ACCP) where she has served on a variety of committees and held numerous leadership roles. Most notably she is a past chair of the Adult Medicine PRN for ACCP and was recognized as a fellow in this organization in 2014.
Practice Site
Dr. Starr practices as a clinical pharmacy specialist at Princeton Baptist Medical Center where she works with an interdisciplinary medical team to the provide direct patient care to the patients admitted to an internal medicine rounding team.
Dr. Starr founded and directed a PGY1 pharmacy residency program from 2008-2017 where she served as the program director for 21 residents. She continues to be heavily involved in this program where she serves as a preceptor for both clinical rotations and residency projects. In 2020, Dr. Starr founded a PGY2 residency in internal medicine and currently serves as the director of this program.
Dr. Starr also holds a faulty appointment with the Department of Medical Education where she serves as a non-physician attending for an Evidenced Based Medicine Rotation offered to second and third year internal medicine medical residents. She is also extensively involved in medical resident education throughout this three-year residency program.
Auburn University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education; credits are recognized nationwide. The Universal Activity Number for this knowledge-based program is 0001-0000-24-013-H01-P and is intended for pharmacists and pharmacy technicians. The initial release date for this home-study program is March 5, 2024 and the intended expiration date is March 5, 2027.
ABN - Auburn University Harrison School of Pharmacy is a Board approved provider of continuing nursing education in Alabama by the Alabama Board of Nursing. Provider Number: ABNP1515.
Available Credit
- 1.20 ABNAuburn University Harrison College of Pharmacy is a board-approved provider of continuing nursing education in Alabama by the Alabama Board of Nursing. Provider Number: ABNP1515
- 1.00 ACPE PharmacyAuburn University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education; credits are recognized nationwide.
Price
Please click ADD TO Cart. You will be directed to your shopping cart for check out or you can proceed to check out by clicking on the shopping cart icon at the top right of your screen.
If you have a COUPON CODE, it can be applied on the shopping cart page or the CHECKOUT page. Please click APPLY TO ORDER.
Proceed to CHECKOUT and fill in your information. Choose your payment method and REVIEW ORDER.
You will be directed to our payment system to complete your order. An order confirmation email will be sent to your email address on file.
Once your order is complete, you will now have access to the course materials. Return to the course page and click TAKE COURSE to proceed.